Yersinia pestis infection in Vietnam. I. Clinical and hematologic aspects.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000907:Antibodies, Bacterial / Q000032:analysis; D001769:Blood / Q000382:microbiology; D001772:Blood Cell Count; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000175:diagnosis; D004352:Drug Resistance, Microbial; D004562:Electrocardiography; D005260:Female; D005334:Fever / Q000209:etiology; D006386:Hemagglutination Tests; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010930:Plague / Q000473:pathology*; D013307:Streptomycin / Q000627:therapeutic use; D013420:Sulfamethoxazole / Q000494:pharmacology / Q000627:therapeutic use; D014295:Trimethoprim / Q000494:pharmacology / Q000627:therapeutic use; D014744:Vietnam; D015010:Yersinia pestis / Q000187:drug effects / Q000302:isolation & purification
D000907:Antibodies, Bacterial; D002701:Chloramphenicol; D014295:Trimethoprim; D013420:Sulfamethoxazole; D013307:Streptomycin